29927-14-8Relevant articles and documents
A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects
Carta, Fabrizio,Di Cesare Mannelli, Lorenzo,Pinard, Melissa,Ghelardini, Carla,Scozzafava, Andrea,McKenna, Robert,Supuran, Claudiu T.
, p. 1828 - 1840 (2015/03/14)
A series of benzene sulfonamide carbonic anhydrase (CA, EC 4.2.1.1) inhibitors which incorporate lipophilic 4-alkoxy- and 4-aryloxy moieties, together with several derivatives of ethoxzolamide and sulfanilamide are reported. These derivatives were investi
Topically active ocular benzothiazole sulfonamide carbonic anhydrase inhibitors
-
, (2008/06/13)
This invention is directed to compounds of the formula STR1 and pharmaceutically acceptable salts thereof wherein R6 is hydrogen or lower alkyl; each R1 is hydrogen, lower alkyl, halogen, nitro, trihaloalkyl, lower alkoxy, formyl, lower alkanoyl, loweralkylamino or diloweralkylamino STR2 X is O, S or NR5 ; R2 is OR7 or NR7 R8 ; each R3 and R4 are independently hydrogen or lower alkyl; R5 R7 and R8 are independently hydrogen or lower alkyl; n is 0-3 and m is 0-6. These compounds are useful for treating glaucoma or assessing corneal function in mammals.
Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
-
, (2008/06/13)
Novel carbonates of 6(or 5)-hydroxy-2-benzothiazolesulfonamide are useful for the topical treatment of elevated intraocular pressure. Ophthalmic compositions include drops and inserts.